title: The addition of interferon gamma to oral bexarotene therapy with photopheresis for Sézary syndrome.
authors.forename: Karen S
authors.initials: KS
authors.lastname: McGinnis
authors.forename: Ravi
authors.initials: R
authors.lastname: Ubriani
authors.forename: Sarah
authors.initials: S
authors.lastname: Newton
authors.forename: Jacqueline M
authors.initials: JM
authors.lastname: Junkins-Hopkins
authors.forename: Carmela C
authors.initials: CC
authors.lastname: Vittorio
authors.forename: Ellen J
authors.initials: EJ
authors.lastname: Kim
authors.forename: Maria
authors.initials: M
authors.lastname: Wysocka
authors.forename: Alain H
authors.initials: AH
authors.lastname: Rook
mesh_terms: D000284:Administration, Oral; D000077610:Bexarotene; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D008875:Middle Aged; D017893:Photopheresis; D011994:Recombinant Proteins; D012751:Sezary Syndrome / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*; D013764:Tetrahydronaphthalenes / Q000008:administration & dosage*
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D013764:Tetrahydronaphthalenes; D000077610:Bexarotene